The digital health space refers to the integration of technology and health care services to improve the overall quality of health care delivery. It encompasses a wide range of innovative and emerging technologies such as wearables, telehealth, artificial intelligence, mobile health, and electronic health records (EHRs). The digital health space offers numerous benefits such as improved patient outcomes, increased access to health care, reduced costs, and improved communication and collaboration between patients and health care providers. For example, patients can now monitor their vital signs such as blood pressure and glucose levels from home using wearable devices and share the data with their doctors in real-time. Telehealth technology allows patients to consult with their health care providers remotely without having to travel to the hospital, making health care more accessible, particularly in remote or rural areas. Artificial intelligence can be used to analyze vast amounts of patient data to identify patterns, predict outcomes, and provide personalized treatment recommendations. Overall, the digital health space is rapidly evolving, and the integration of technology in health

Saturday, December 11, 2021

A Piece of Rice offers great help to those with Hypertension and Congestive Heart Failure



Cardiovascular disease represents an astronomical disease burden globally. In the USA, hypertension and congestive heart failure (CHF) significantly increase the risk for adverse events such as stroke or heart attack. A million deaths with these diseases occur annually as the primary or contributing cause. By combining proprietary implantable sensors and technology for continuous patient data acquisition/transmission, Qura plans to revolutionize telemedicine, disease management, and patient care. CEO William Hendren, MD, details how their patented Qsmart™ sensor, a 100% autonomous and programmable device the size of a grain of rice, provides uninterrupted active monitoring of patient pressure data that can anticipate negative cardiovascular events and improve patient outcomes. This breakthrough technology has been validated both in vitro and in vivo - in a controlled lab environment and within a living organism. With a team that combines medical knowledge with engineering and commercialization expertise, Qura is poised to transform the 33+B hypertension and CHF market. Presenter: William Hendren, MD, CEO Health Moonshot: Revolutionize the management of chronic cardiovascular diseases such as hypertension and advanced congestive heart failure using wireless implantable pressure-monitoring devices to collect actionable data in real-time. Connect with the team at Qura: https://startuphealth.com/qura Invest in Health Moonshots: https://healthmoonshots.com










Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)